摘要
目的探讨弥漫大B细胞淋巴瘤(DLBCL)患者细胞免疫状态与国际预后指数(IPI)的关系。方法初治DLBCL患者52例,按照IPI积分分为4组(低危组17例、低中危组16例、中高危组12例、高危组7例),采用流式细胞术检测各DLBCL组与健康对照组(43例)T淋巴细胞亚群(包括CD3、CD3C4、CD3CD8)、NK细胞的绝对计数值及CD;/CD],各组间比较并分析IPI的5个指标与各T淋巴细胞亚群绝对值的相关陆。结果DLBCL高危组的CD3细胞(1570.9±370.5)个/μl,较其他IPI组高;DLBCL4组的CD4细胞数均低于健康对照组的(751.3±367.4)个/μl;DLBCL高危组的cD;细胞(1055.9±523.8)个/μl,较健康对照组及其他IPl分组明显升高;中高危组与高危组的CD]/CD;LL值(1.0±0.2、0.7±1.0)降低明显,与健康对照组、低危组、低中危组比较差异均有统计学意义(P〈0.05);中高危组与高危组NK细胞较健康对照组明显降低[(199.5±68.4)/m、(171.9±126.9)/μl]。淋巴瘤患者的年龄、临床分期、全身状态与患者外周血T淋巴细胞亚群中的CD;细胞数、CD8细胞数以及CD4/CD8 比值有相关性。结论初治的DLBCL患者细胞免疫状态与1PI有关;随着IPI积分的增加,DLBCL患者免疫抑制与紊乱加重,NK细胞功能越差,预后也更差。
Objective To explore the relationship between the international prognosis indexes(IPI) and the cell-mediated immunity condition in DLBCL patients. Methods 52 DLBCL patients were divided into 4 groups and the FCM was used to examine the T lymphocyte subsets, including CD3,CD4,CD8 NK cells . T lymphocyte subsets absolute value and CD4/CD8 ratio were examined. Correlation with IPI were compared among groups. Results CD; cells in high risk group [(1570.9±370.5)/μl]were higher than other IPI groups; CD4 cells in DLBCL groups were all lower than normal group(751.3±367.4)/μl]; CD8 cells in high risk group [( 1055.9±523.8)/μ1] were higher than other groups; CD4/CD8 ratio in middle-high risk group and high risk group (1.0±0.2,0.7±1.0) were lower than other IPI groups and normal group; NK cells in middle-high risk group and high risk group were lower than the normal group [(199.5±68.4)/μl,(171.9±126.9)/μl]; Age, clinical stage,body state had correlated with the CD3 ,CD4 cells and CD4/CD8 ratio of the DLBCL patients' peripheral blood T lymphosyte subsets. Conclusions The immunity condition in DLBCL patients has correlated with IPI; With increasing IPI value, the immunity depression and disorder become more serious, NK cells function become worse, and the prognosis is bad too.
出处
《白血病.淋巴瘤》
CAS
2012年第5期285-287,共3页
Journal of Leukemia & Lymphoma
关键词
淋巴瘤
大细胞
弥漫性
免疫
细胞
T淋巴细胞亚群
杀伤细胞
天然
国际预后指数
Lymphoma, large cell, diffuse
Immunity, cellular
T lymphocyte subsets
Killer cells, natural
International prognosis index